Firefly Neuroscience, Inc.
AIFF
$2.24
$0.2613.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.03% | -43.97% | 85.82% | -241.61% | 11.75% |
| Total Depreciation and Amortization | -20.00% | -- | -100.00% | 375.00% | 0.00% |
| Total Amortization of Deferred Charges | 11.11% | -58.14% | -- | -- | -- |
| Total Other Non-Cash Items | -62.68% | 123.18% | -96.68% | 872.20% | -54.42% |
| Change in Net Operating Assets | 18.49% | 127.29% | -22.91% | -158.22% | 278.79% |
| Cash from Operations | -21.30% | 37.74% | 4.82% | -106.16% | 51.65% |
| Capital Expenditure | 73.26% | -616.67% | -71.43% | 91.25% | -1,900.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 104.71% |
| Cash from Investing | 73.26% | 96.37% | -33,785.71% | 90.79% | 14.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -71.00% | -- | -- |
| Repurchase of Common Stock | -11,905.26% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,415.79% | -101.67% | -88.93% | 447.12% | -46.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.94% | 56.08% | -146.89% | 1,233.62% | -33.49% |